ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against...
Ingrid Haugen
Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies’ laboratory, launches a...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist (VKA) for unmet needs...
Persistent Launches Population Health Management Solution Using Microsoft Azure OpenAI Service
2 min read
Persistent Systems (BSE: PERSISTENT) and (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today launched an innovative Generative...
Technoderma Medicines, Inc. (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin...
ALZpath, Inc. (ALZpath), a leader in Alzheimer’s diagnostics, announced new findings published online today in JAMA Neurology showing that its proprietary blood-based...
Abbott (NYSE: ABT) today announced the first global procedures have been conducted using the company’s new Volt™ Pulsed...
Global advocacy campaign, Human Change, launched today in Davos during the World Economic Forum to raise awareness and instigate a...
The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a...
